methyl 4,5,6,7-tetrahydro-4-[(phenylmethoxy)amino]-2H-pyrazolo[3,4-c]pyridine-7-carboxylate | 478628-01-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl 4,5,6,7-tetrahydro-4-[(phenylmethoxy)amino]-2H-pyrazolo[3,4-c]pyridine-7-carboxylate
• 英文别名: 7-methyl 4,5,6,7-tetrahydro-4-[(phenylmethoxy)amino]-2H-pyrazolo[3,4-c]pyridine-7-carboxylate；methyl 4-(phenylmethoxyamino)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-7-carboxylate
• CAS: 478628-01-2
• 化学式: C₁₅H₁₈N₄O₃
• 分子量: 302.333
• InChiKey: VHIGSGMUCCPWFE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  88.3
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  6-(tert-butyl) 7-methyl 4-((benzyloxy)amino)-2-trityl-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine-6,7-dicarboxylate 在 盐酸 、 Ammonium hydroxide 作用下， 以 乙酸乙酯 、 水 为溶剂， 反应 3.0h， 生成 methyl 4,5,6,7-tetrahydro-4-[(phenylmethoxy)amino]-2H-pyrazolo[3,4-c]pyridine-7-carboxylate
  参考文献：
  名称：

  Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents

  摘要：

  这项发明涉及一般式(I)的新杂环化合物及其与碱或酸形成的盐： 该发明还涉及制备这些化合物的方法，以及它们作为药物的用途，特别是作为抗菌剂。

  公开号：

  US20050245505A1

文献信息

• [EN] COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：ENTASIS THERAPEUTICS INC

  公开号：WO2018208769A1

  公开（公告）日：2018-11-15

  Provided herein are antibacterial compounds represented by Formula I, or a pharmaceutically acceptable salt thereof, wherein X, Y, R4, R5, and R6 are as defined herein. Also provided are pharmaceutical compositions comprising the compounds of Formula I.

  本文提供了由化学式I表示的抗菌化合物，或其药用可接受的盐，其中X、Y、R4、R5和R6如本文所定义。还提供了包含化合物I的药物组合物。
• Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
  申请人：AVENTIS PHARMA S.A.

  公开号：US20040157826A1

  公开（公告）日：2004-08-12

  The invention relates to novel heterocyclic compounds of general formula (I), and their salts with a base or an acid: 1 The invention also relates to a method for preparing these compounds, and to their use as medicaments, in particular as antibacterials and &bgr;-lactamase inhibitors.

  这项发明涉及一般式(I)的新异环化合物及其与碱或酸的盐：1。该发明还涉及制备这些化合物的方法，并将它们用作药物，特别是作为抗菌药物和β-内酰胺酶抑制剂。
• NOVEL HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTIBACTERIALS AND BETA-LACTAMASE INHIBITORS
  申请人：Lampilas Maxime

  公开号：US20090018329A1

  公开（公告）日：2009-01-15

  The invention relates to novel heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a method for preparing these compounds, and to their use as medicaments, in particular as antibacterials and β-lactamase inhibitors.

  该发明涉及一种新型杂环化合物，其通式为（I），以及它们与酸或碱的盐：该发明还涉及一种制备这些化合物的方法，并将其用作药物，特别是作为抗菌剂和β-内酰胺酶抑制剂。
• Compounds and methods for treating bacterial infections
  申请人：Entasis Therapeutics, Inc.

  公开号：US11046694B2

  公开（公告）日：2021-06-29

  Provided herein are antibacterial compounds represented by Formula I, or a pharmaceutically acceptable salt thereof, wherein X, Y, R4, R5, and R6 are as defined herein. Also provided are pharmaceutical compositions comprising the compounds of Formula I.

  本文提供了由式 I 代表的抗菌化合物或其药学上可接受的盐，其中 X、Y、R4、R5 和 R6 如本文所定义。还提供了包含式 I 化合物的药物组合物。
• COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
  申请人：Entasis Therapeutics, Inc.

  公开号：EP3630111A1

  公开（公告）日：2020-04-08